Daniel Eng

As the demand for new medicines grows, so does the need for better information to manage and execute the R&D processes. There is huge pressure to make informed decisions, especially during the project's early stages when the risk is high and before downstream costs are added. Pfizer spends billions on research projects annually. At Pfizer Global R&D where the company's drug discovery takes place, research scientists and managers require vast amounts of up-to-the-minute information on lab results, submission status, and project schedules to move new research forward quickly. Management must constantly analyze the entire portfolio of new medicines in discovery to look for opportunities, trends, and areas where attention is needed. Researchers and managers strive to bring t... (more)